HOPS Study: A Conceptual Replication
Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Jul 6, 2020
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The HOPS Study is researching a program designed to help students who struggle with organization, time management, and planning skills, particularly those with executive dysfunction and Attention Deficit Hyperactivity Disorder (ADHD). The study aims to see if this "Homework, Organization, and Planning Skills" (HOPS) intervention is effective when delivered by school staff in a regular classroom setting. They will evaluate how well the program is implemented and how factors like school organization influence the results.
To participate, students must be in grades 6 through 8, be in a general education classroom, and be nominated by a teacher who feels they need this help. Parents or guardians must give permission for their child to join the study. It's important to note that students in special education classes for most of the day or those who have previously used the HOPS program cannot participate. The study is currently recruiting participants, and selected students can expect to receive support from trained school staff to improve their organizational skills.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • STUDENTS
- • 1. Male or female students in grades 6 through 8.
- • 2. Student is in a general education classroom.
- • 3. Student is nominated for the study by at least one teacher(s) who rates the student as needing the intervention and having OTMP skills deficits that have a negative impact on academic performance (rating \> 3 on a 4-point scale on at least one of four interference items of COSS-T)
- • 4. Parental/guardian permission (informed consent) and student assent.
- • PARENTS
- • 1. The parent/legal guardian's child is eligible for the study
- • SCHOOL PROVIDERS
- • 1. School providers will be chosen by school administrators as personnel who are capable of delivering the HOPS intervention (HOPS-ST) in the school context.
- • RESEARCH PROVIDER
- • 1. A person with experience providing instruction or intervention to students in a school context.
- • 2. A member of the research team who will provide the HOPS intervention to the HOPS-RT condition
- • 3. Has consented to be a "secondary research participant"
- Exclusion Criteria:
- • STUDENTS
- • 1. Students will be excluded if they are in a pull-out special education classroom for more than 50% of the day, because the organizational demands for these students may differ from those placed mostly in general education.
- • 2. Students with a one-to-one aide will be excluded because the presence of an aide substantially alters how an organizational intervention is implemented.
- • 3. Students from families in which both caregivers do not speak English will be excluded because the program has not yet been developed for non-English speakers.
- • 4. Students who may have participated in HOPS before (as it is a commercially-available program) is not eligible to participate in this study.
- • PARENTS
- • 1. Parents who are not fluent in English are excluded since at this time because the intervention and many of the study outcome measures are not available in other languages.
- • SCHOOL PROVIDERS
- • 1. Any school professional who declines to participate will not be enrolled.
- • RESEARCH PROVIDERS
- • 1. Does not consent to be a "secondary research participant"
About Children's Hospital Of Philadelphia
The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Thomas Power, PhD
Principal Investigator
Children's Hospital of Philadelphia
Jenelle Nissley-Tsiopinis, PhD
Principal Investigator
Children's Hospital of Philadelphia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials